510(k) K884829

EBV EARLY ANTIGEN (R+D) by Hillcrest Biologicals — Product Code JRY

K884829 is an FDA 510(k) premarket notification submitted by Hillcrest Biologicals for the device "EBV EARLY ANTIGEN (R+D)". The FDA issued a decision of Substantially Equivalent on April 12, 1989. The device falls under product code JRY (Antiserum, Fluorescent, Epstein-Barr Virus), a Class I device regulated under 21 CFR 866.3235. Hillcrest Biologicals has at least 10 other 510(k) clearances on record.

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
April 12, 1989
Date Received
November 18, 1988
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
Antiserum, Fluorescent, Epstein-Barr Virus
Device Class
Class I
Regulation Number
866.3235
Review Panel
MI
Submission Type